FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969586911> ?p ?o ?g. }

• W2969586911 endingPage "7003" @default.
• W2969586911 startingPage "6995" @default.
• W2969586911 abstract "Abstract Purpose: Anti-CD19 chimeric antigen receptor (CAR) T cells represent a novel immunotherapy and are highly effective in treating relapsed/refractory B-cell non-Hodgkin's lymphoma (B-NHL). How tumor microenvironment influences clinical response to CAR T therapy remains of great interest. Patients and Methods: A phase I, first-in-human, dose-escalation study of anti-CD19 JWCAR029 was conducted in refractory B-NHL (NCT03355859) and 10 patients received CAR T cells at an escalating dose of 2.5 × 107(n = 3), 5 × 107(n = 4), and 1 × 108(n = 3) cells. Core needle biopsy was performed on tumor samples collected from diffuse large B-cell lymphoma patients on Day −6 (1 day before lymphodepletion) and on Day 11 after CAR T-cell infusion when adequate CAR T-cell expansion was detected. Results: The overall response rate was 100%, with 6 of 9 (66.7%) evaluable patients achieving complete remission. The most common adverse events of grade 3 or higher were neutropenia (10/10, 100%), anemia (3/10, 30%), thrombocytopenia (3/10, 30%), and hypofibrinogenemia (2/10, 20%). Grade 1 cytokine release syndrome occurred in all patients and grade 3 neurotoxicity in 1 patient. The average peak levels of peripheral blood CAR T cells and cytokines were similar in 3 different dose levels, but CAR T cells were significantly higher in patients achieved complete remission on Day 29. Meanwhile, RNA sequencing identified gene expression signatures differentially enriched in complete and partial remission patients. Increased tumor-associated macrophage infiltration was negatively associated with remission status. Conclusions: JWCAR029 was effective and safe in treating refractory B-NHL. The composition of the tumor microenvironment has a potential impact in CAR T therapy response." @default.
• W2969586911 created "2019-08-29" @default.
• W2969586911 creator A5003886138 @default.
• W2969586911 creator A5012278873 @default.
• W2969586911 creator A5017214368 @default.
• W2969586911 creator A5017506560 @default.
• W2969586911 creator A5019909333 @default.
• W2969586911 creator A5020626623 @default.
• W2969586911 creator A5021648197 @default.
• W2969586911 creator A5027475930 @default.
• W2969586911 creator A5049242358 @default.
• W2969586911 creator A5060506542 @default.
• W2969586911 creator A5061935485 @default.
• W2969586911 creator A5065668771 @default.
• W2969586911 creator A5069311189 @default.
• W2969586911 creator A5071860246 @default.
• W2969586911 creator A5091188164 @default.
• W2969586911 date "2019-12-01" @default.
• W2969586911 modified "2023-10-17" @default.
• W2969586911 title "Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma" @default.
• W2969586911 cites W1823780969 @default.
• W2969586911 cites W1973759139 @default.
• W2969586911 cites W2034400622 @default.
• W2969586911 cites W2059762191 @default.
• W2969586911 cites W2082708772 @default.
• W2969586911 cites W2084155879 @default.
• W2969586911 cites W2087134443 @default.
• W2969586911 cites W2119147717 @default.
• W2969586911 cites W2121346123 @default.
• W2969586911 cites W2123105952 @default.
• W2969586911 cites W2127107746 @default.
• W2969586911 cites W2142530756 @default.
• W2969586911 cites W2179454156 @default.
• W2969586911 cites W2255908040 @default.
• W2969586911 cites W2342423058 @default.
• W2969586911 cites W2349584574 @default.
• W2969586911 cites W2496641039 @default.
• W2969586911 cites W2530492154 @default.
• W2969586911 cites W2594615455 @default.
• W2969586911 cites W2626812824 @default.
• W2969586911 cites W2744261860 @default.
• W2969586911 cites W2766860384 @default.
• W2969586911 cites W2773804840 @default.
• W2969586911 cites W2801641802 @default.
• W2969586911 cites W2807819616 @default.
• W2969586911 cites W2887577080 @default.
• W2969586911 cites W2892758519 @default.
• W2969586911 cites W2893691711 @default.
• W2969586911 cites W2898740977 @default.
• W2969586911 cites W2903062212 @default.
• W2969586911 doi "https://doi.org/10.1158/1078-0432.ccr-19-0101" @default.
• W2969586911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31444250" @default.
• W2969586911 hasPublicationYear "2019" @default.
• W2969586911 type Work @default.
• W2969586911 sameAs 2969586911 @default.
• W2969586911 citedByCount "61" @default.
• W2969586911 countsByYear W29695869112020 @default.
• W2969586911 countsByYear W29695869112021 @default.
• W2969586911 countsByYear W29695869112022 @default.
• W2969586911 countsByYear W29695869112023 @default.
• W2969586911 crossrefType "journal-article" @default.
• W2969586911 hasAuthorship W2969586911A5003886138 @default.
• W2969586911 hasAuthorship W2969586911A5012278873 @default.
• W2969586911 hasAuthorship W2969586911A5017214368 @default.
• W2969586911 hasAuthorship W2969586911A5017506560 @default.
• W2969586911 hasAuthorship W2969586911A5019909333 @default.
• W2969586911 hasAuthorship W2969586911A5020626623 @default.
• W2969586911 hasAuthorship W2969586911A5021648197 @default.
• W2969586911 hasAuthorship W2969586911A5027475930 @default.
• W2969586911 hasAuthorship W2969586911A5049242358 @default.
• W2969586911 hasAuthorship W2969586911A5060506542 @default.
• W2969586911 hasAuthorship W2969586911A5061935485 @default.
• W2969586911 hasAuthorship W2969586911A5065668771 @default.
• W2969586911 hasAuthorship W2969586911A5069311189 @default.
• W2969586911 hasAuthorship W2969586911A5071860246 @default.
• W2969586911 hasAuthorship W2969586911A5091188164 @default.
• W2969586911 hasBestOaLocation W29695869111 @default.
• W2969586911 hasConcept C121608353 @default.
• W2969586911 hasConcept C126322002 @default.
• W2969586911 hasConcept C203014093 @default.
• W2969586911 hasConcept C2776107976 @default.
• W2969586911 hasConcept C2776694085 @default.
• W2969586911 hasConcept C2777063308 @default.
• W2969586911 hasConcept C2777701055 @default.
• W2969586911 hasConcept C2778559949 @default.
• W2969586911 hasConcept C2779338263 @default.
• W2969586911 hasConcept C2780850621 @default.
• W2969586911 hasConcept C3875195 @default.
• W2969586911 hasConcept C71924100 @default.
• W2969586911 hasConcept C90924648 @default.
• W2969586911 hasConceptScore W2969586911C121608353 @default.
• W2969586911 hasConceptScore W2969586911C126322002 @default.
• W2969586911 hasConceptScore W2969586911C203014093 @default.
• W2969586911 hasConceptScore W2969586911C2776107976 @default.
• W2969586911 hasConceptScore W2969586911C2776694085 @default.
• W2969586911 hasConceptScore W2969586911C2777063308 @default.
• W2969586911 hasConceptScore W2969586911C2777701055 @default.
• W2969586911 hasConceptScore W2969586911C2778559949 @default.

• next